BSE filing, NSE: VAKRANGEE. Summary written from the filing by ALFA Finder's alert engine.
Vakrangee Ltd: key numbers
- Share price
- ₹5.69
- Market cap
- ₹616.6 Cr
- Revenue (annual)
- ₹254.8 Cr
- Net profit (annual)
- ₹11.27 Cr
- P/E (TTM)
- 56.8×Sector 43.1×
- Promoter holding
- 40.04%-0.01% QoQ
- FII holding
- 0.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vakrangee Ltd
All →Vakrangee Investor Presentation: Key Takeaways
Q2 FY27 consolidated total income ₹6,408.9L (+10.7% QoQ), EBITDA ₹945.9L (15.3% margin), PAT ₹272.8L (+20.9% QoQ). Debt-free; quarterly GTV ₹12,976.8 Cr.
Vakrangee Results Update
Vakrangee reported Q2 FY27 PAT of ₹272.8 Lakh, up 20.9% QoQ, on 10.7% revenue growth. GTV reached ₹12,976 crore across 23,885 outlets.
Vakrangee Q2 FY27 Results: Net Profit ₹2.7 Cr, Down 10.0% YoY
Vakrangee Ltd reported revenue from operations of ₹61.7 Cr (-10.7% YoY) and net profit of ₹2.7 Cr (-10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.7 Cr · -10.0% YoY
Vakrangee Board Meeting Date
Vakrangee Limited has notified a board meeting on 28 October 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. This is an advance notice; the meeting has not yet been held.
Vakrangee Other Announcement
Vakrangee Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Vakrangee Annual General Meeting
Vakrangee shareholders passed six resolutions at its 36th AGM, including MD re-appointment and MOA alteration. The meeting was held via video conference on September 23, 2026.
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.